| Literature DB >> 35547874 |
Shengpeng Jiang1, Yi Xue1, Ming Li1, Chengwen Yang1, Daguang Zhang1, Qingxin Wang1, Jing Wang1, Jie Chen1, Jinqiang You1, Zhiyong Yuan1, Xiaochun Wang2, Xiaodong Zhang2, Wei Wang1.
Abstract
As a useful tool, artificial intelligence has surpassed human beings in many fields. Artificial intelligence-based automated radiotherapy planning strategies have been proposed in lots of cancer sites and are the future of treatment planning. Postmastectomy radiotherapy (PMRT) decreases local recurrence probability and improves overall survival, and volumetric modulated arc therapy (VMAT) has gradually become the mainstream technique of radiotherapy. However, there are few customized effective automated treatment planning schemes for postmastectomy VMAT so far. This study investigated an artificial intelligence based automated planning using the MD Anderson Cancer Center AutoPlan (MDAP) system and Pinnacle treatment planning system (TPS), to effectively generate high-quality postmastectomy VMAT plans. In this study, 20 patients treated with PMRT were retrospectively investigated, including 10 left- and 10 right-sided postmastectomy patients. Chest wall and the supraclavicular, subclavicular, and internal mammary regions were delineated as target volume by radiation oncologists, and 50 Gy in 25 fractions was prescribed. Organs at risk including heart, spinal cord, left lung, right lung, and lungs were also contoured. All patients were planned with VMAT using 2 arcs. An optimization objective template was summarized based on the dose of clinical plans and requirements from oncologists. Several treatment planning parameters were investigated using an artificial intelligence algorithm, including collimation angle, jaw collimator mode, gantry spacing resolution (GSR), and number of start optimization times. The treatment planning parameters with the best performance or that were most preferred were applied to the automated treatment planning method. Dosimetric indexes of automated treatment plans (autoplans) and manual clinical plans were compared by the paired t-test. The jaw tracking mode, 2-degree GSR, and 3 rounds of optimization were selected in all the PMRT autoplans. Additionally, the 350- and 10-degree collimation angles were selected in the left- and right-sided PMRT autoplans, respectively. The uniformity index and conformity index of the planning target volume, mean heart dose, spinal cord D0.03cc, mean lung dose, and V5Gy and V20Gy of the lung of autoplans were significantly better compared with the manual clinical plans. An artificial intelligence-based automated treatment planning method for postmastectomy VMAT has been developed to ensure plan quality and improve clinical efficiency.Entities:
Keywords: MD Anderson Cancer Center AutoPlan (MDAP); artificial intelligence; automated treatment planning; postmastectomy radiotherapy (PMRT); volumetric modulated arc therapy (VMAT)
Year: 2022 PMID: 35547874 PMCID: PMC9084926 DOI: 10.3389/fonc.2022.871871
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Structure volumes of left-sided PMRT cases.
| Case no. | PTV | Left lung | Right lung | Heart | Overlap of PTV and left lung |
|---|---|---|---|---|---|
| 1 | 967.4 | 928.8 | 1,334.3 | 497.7 | 59.3 |
| 2 | 1,086.4 | 992.2 | 1,343.8 | 609.6 | 78.9 |
| 3 | 1,283.1 | 771.3 | 1,224.8 | 642.4 | 59.6 |
| 4 | 1,504.6 | 805.2 | 984.5 | 565.5 | 37.5 |
| 5 | 1,322.3 | 1,114.3 | 1,180.7 | 621.9 | 70.1 |
| 6 | 1,035.5 | 916.5 | 1,212.4 | 664.8 | 55.2 |
| 7 | 1,104.8 | 1,050.5 | 1,359.7 | 503.3 | 72.8 |
| 8 | 1,280.9 | 1,132.8 | 1,423.5 | 657.7 | 79.6 |
| 9 | 1,402.0 | 708.1 | 955.5 | 651.1 | 50.7 |
| 10 | 1,139.0 | 866.0 | 1,095.6 | 620.4 | 60.2 |
Volumes were given in cc.
Structure volumes of right-sided PMRT cases.
| Case no. | PTV | Left lung | Right lung | Heart | Overlap of PTV and right lung |
|---|---|---|---|---|---|
| 1 | 1,009.3 | 1,351.7 | 1,512.8 | 546.8 | 125.5 |
| 2 | 1,265.2 | 838.6 | 1,042.4 | 709.3 | 81.7 |
| 3 | 1,217.5 | 1,069.3 | 1,277.7 | 549.9 | 103.7 |
| 4 | 1,284.3 | 840.6 | 1,091.1 | 562.6 | 94.5 |
| 5 | 913.9 | 1,586.6 | 1,955.3 | 612.9 | 107.0 |
| 6 | 1,178.5 | 1,549.0 | 1,748.4 | 537.5 | 110.9 |
| 7 | 1,476.4 | 805.8 | 1,210.2 | 606.2 | 104.4 |
| 8 | 1,311.6 | 1,534.8 | 1,610.6 | 526.6 | 91.3 |
| 9 | 1,394.2 | 755.9 | 1,001.6 | 579.9 | 71.0 |
| 10 | 1,147.4 | 1,108.3 | 1,391.9 | 792.7 | 115.1 |
Volumes were given in cc.
Generation method of auxiliary structures.
| Auxiliary structures | Generation method |
|---|---|
| PTV-3mm | Create contraction of PTV with a 3-mm margin |
| PTV 5mmring | Create ring of PTV with a 5-mm margin |
| PTV 1cmring | Create ring of PTV between the 5-mm and 1-cm margin |
| PTV 2cmring | Create ring of PTV between the 1-cm to 2-cm margin |
| PTV 3cmring | Create ring of PTV between the 2-cm to 3-cm margin |
| nt | Create subtraction of PTV and PTV rings from the body |
| Left lung avoid | Create subtraction of PTV and PTV 5mmring from left lung |
| Right lung avoid | Create subtraction of PTV and PTV 5mmring from right lung |
| Heart avoid | Create subtraction of PTV and PTV 5mmring from heart |
Optimization objective template of postmastectomy VMAT plans.
| ROI | Type | Target cGy | % Volume | Weight | a |
|---|---|---|---|---|---|
| PTV | Max Dose | 6,300 | 80 | ||
| PTV | Max Dose | 6,300 | 80 | ||
| PTV | Max Dose | 6,300 | 80 | ||
| PTV | Min DVH | 6,000 | 98 | 100 | |
| PTV | Min DVH | 5,800 | 99 | 100 | |
| PTV | Min Dose | 5,500 | 100 | ||
| PTV-3mm | Min Dose | 6,000 | 100 | ||
| PTV 5mmring | Max Dose | 6,000 | 30 | ||
| PTV 1cmring | Max Dose | 5,500 | 30 | ||
| PTV 2cmring | Max Dose | 5,000 | 30 | ||
| PTV 3cmring | Max Dose | 4,500 | 30 | ||
| nt | Max Dose | 3,500 | 30 | ||
| Left lung | Max DVH | 2,000 | 25 | 100 | |
| Right lung | Max DVH | 2,000 | 25 | 100 | |
| Lungs | Max DVH | 500 | 40 | 100 | |
| PTV 1cmring | Max EUD | 0 | 6e-09 | 1 | |
| PTV 2cmring | Max EUD | 0 | 1e-08 | 1 | |
| PTV 3cmring | Max EUD | 0 | 1.5e-08 | 1 | |
| nt | Max EUD | 0 | 1e-07 | 1 | |
| Spinal cord | Max EUD | 0 | 1e-08 | 10 | |
| Left lung avoid | Max EUD | 0 | 1e-06 | 1 | |
| Right lung avoid | Max EUD | 0 | 1e-06 | 1 | |
| Heart avoid | Max EUD | 0 | 1e-06 | 1 |
Dosimetric results (mean ± standard deviation) of left-sided postmastectomy VMAT plans with different collimation angles.
| 350 degree | 5 degree | p | 10 degree | p | 355 degree | p | |
|---|---|---|---|---|---|---|---|
| PTV CI | 0.850±0.011 | 0.845±0.016 | 0.133 | 0.845±0.012 | 0.092 | 0.848±0.015 | 0.300 |
| PTV HI | 0.148±0.015 | 0.151±0.025 | 0.401 | 0.156±0.019 | 0.030 | 0.149±0.019 | 0.834 |
| Heart Dmean (Gy) | 7.41±1.06 | 7.59±1.26 | 0.031 | 7.65±1.23 | 0.116 | 7.48±1.14 | 0.400 |
| Spinal cord D0.03cc (Gy) | 14.76±4.25 | 14.87±4.39 | 0.859 | 16.29±6.61 | 0.295 | 14.31±2.88 | 0.629 |
| Ipsilateral lung Dmean (Gy) | 13.17±0.72 | 13.49±0.97 | 0.046 | 13.52±0.85 | 0.002 | 13.27±0.86 | 0.356 |
| Ipsilateral lung V5Gy (%) | 48.7±4.2 | 50.7±6.2 | 0.070 | 51.6±5.2 | <0.001 | 49.8±5.9 | 0.185 |
| Ipsilateral lung V20Gy (%) | 23.0±1.3 | 23.3±1.6 | 0.144 | 23.4±1.4 | 0.001 | 23.1±1.4 | 0.487 |
| Contralateral lung Dmean (Gy) | 2.69±0.58 | 2.59±0.54 | 0.052 | 2.61±0.62 | 0.207 | 2.75±0.61 | 0.429 |
| Contralateral lung V5Gy (%) | 13.8±4.3 | 13.2±4.0 | 0.298 | 12.8±4.7 | 0.320 | 14.6±4.4 | 0.323 |
| Lungs Dmean (Gy) | 7.24±0.61 | 7.33±0.74 | 0.751 | 7.34±0.73 | 0.065 | 7.31±0.69 | 0.183 |
aComparison of 350 degree to 5 degree.
bComparison of 350 degree to 10 degree.
cComparison of 350 degree to 355 degree.
Dosimetric results (mean ± standard deviation) of right-sided postmastectomy VMAT plans with different collimation angles.
| 10 degree | 5 degree | p | 350 degree | p | 355 degree | p | |
|---|---|---|---|---|---|---|---|
| PTV CI | 0.846±0.012 | 0.842±0.015 | 0.242 | 0.837±0.017 | 0.062 | 0.841±0.016 | 0.252 |
| PTV HI | 0.150±0.019 | 0.154±0.022 | 0.080 | 0.161±0.026 | 0.063 | 0.156±0.022 | 0.154 |
| Heart Dmean (Gy) | 3.47±0.81 | 3.36±0.81 | 0.101 | 3.39±0.90 | 0.507 | 3.46±0.91 | 0.094 |
| Spinal cord D0.03cc (Gy) | 15.46±3.69 | 15.73±2.22 | 0.796 | 12.68±3.61 | 0.039 | 14.56±2.55 | 0.128 |
| Ipsilateral lung Dmean (Gy) | 13.65±0.72 | 13.72±0.71 | 0.154 | 13.99±0.78 | 0.002 | 13.86±0.73 | 0.005 |
| Ipsilateral lung V5Gy (%) | 49.3±3.7 | 49.9±3.4 | 0.132 | 51.8±4.1 | 0.006 | 51.1±4.0 | 0.013 |
| Ipsilateral lung V20Gy (%) | 24.2±0.9 | 24.2±0.9 | 0.624 | 24.3±1.0 | 0.093 | 24.3±0.8 | 0.012 |
| Contralateral lung Dmean (Gy) | 1.97±0.29 | 1.89±0.38 | 0.354 | 1.90±0.38 | 0.277 | 1.92±0.37 | 0.428 |
| Contralateral lung V5Gy (%) | 7.6±2.7 | 7.2±3.9 | 0.640 | 6.3±2.7 | 0.140 | 6.7±3.1 | 0.261 |
| Lungs Dmean (Gy) | 8.41±0.63 | 8.43±0.62 | 0.544 | 8.57±0.69 | 0.014 | 8.52±0.69 | 0.040 |
aComparison of 10 degree to 5 degree.
bComparison of 10 degree to 350 degree.
cComparison of 10 degree to 355 degree.
Dosimetric results (mean ± standard deviation) of postmastectomy VMAT plans with jaw tracking and fixed jaw.
| Jaw tracking (left-side) | Fixed jaw (left-side) | p (left-side) | Jaw tracking (right-side) | Fixed jaw (right-side) | p (right-side) | |
|---|---|---|---|---|---|---|
| PTV CI | 0.850±0.011 | 0.849±0.013 | 0.208 | 0.846±0.012 | 0.848±0.015 | 0.235 |
| PTV HI | 0.148±0.015 | 0.145±0.016 | 0.006 | 0.150±0.019 | 0.144±0.020 | 0.054 |
| Heart Dmean (Gy) | 7.41±1.06 | 7.90±1.10 | <0.001 | 3.47±0.81 | 3.92±0.74 | <0.001 |
| Spinal cord D0.03cc (Gy) | 14.76±4.25 | 16.67±4.05 | 0.017 | 15.46±3.69 | 15.09±3.06 | 0.669 |
| Ipsilateral lung Dmean (Gy) | 13.17±0.72 | 13.61±0.73 | <0.001 | 13.65±0.72 | 14.19±0.74 | <0.001 |
| Ipsilateral lung V5Gy (%) | 48.7±4.2 | 53.2±5.1 | <0.001 | 49.3±3.7 | 54.2±4.5 | <0.001 |
| Ipsilateral lung V20Gy (%) | 23.0±1.3 | 23.1±1.3 | 0.115 | 24.2±0.9 | 24.2±1.0 | 0.543 |
| Contralateral lung Dmean (Gy) | 2.69±0.58 | 2.93±0.57 | 0.004 | 1.97±0.29 | 2.19±0.35 | 0.005 |
| Contralateral lung V5Gy (%) | 13.8±4.3 | 15.2±4.3 | 0.175 | 7.6±2.7 | 8.5±2.8 | 0.041 |
| Lungs Dmean (Gy) | 7.24±0.61 | 7.56±0.64 | <0.001 | 8.41±0.63 | 8.82±0.64 | <0.001 |
Dosimetric results (mean ± standard deviation) of postmastectomy VMAT plans with 2 degree and 4 degree gantry spacing resolution.
| 2 degree (left-side) | 4 degree (left-side) | p (left-side) | 2 degree (right-side) | 4 degree (right-side) | p (right-side) | |
|---|---|---|---|---|---|---|
| PTV CI | 0.850±0.011 | 0.849±0.010 | 0.089 | 0.846±0.012 | 0.841±0.014 | 0.013 |
| PTV HI | 0.148±0.015 | 0.150±0.012 | 0.220 | 0.150±0.019 | 0.156±0.018 | 0.012 |
| Heart Dmean (Gy) | 7.41±1.06 | 7.66±1.09 | <0.001 | 3.47±0.81 | 3.66±0.94 | 0.006 |
| Spinal cord D0.03cc (Gy) | 14.76±4.25 | 15.19±3.65 | 0.243 | 15.46±3.69 | 16.35±4.09 | 0.093 |
| Ipsilateral lung Dmean (Gy) | 13.17±0.72 | 13.34±0.69 | 0.002 | 13.65±0.72 | 13.78±0.64 | 0.002 |
| Ipsilateral lung V5Gy (%) | 48.7±4.2 | 50.0±4.9 | 0.010 | 49.3±3.7 | 49.7±3.5 | 0.110 |
| Ipsilateral lung V20Gy (%) | 23.0±1.3 | 23.3±1.1 | <0.001 | 24.2±0.9 | 24.5±0.7 | 0.001 |
| Contralateral lung Dmean (Gy) | 2.69±0.58 | 2.71±0.60 | 0.704 | 1.97±0.29 | 2.00±0.28 | 0.302 |
| Contralateral lung V5Gy (%) | 13.8±4.3 | 14.0±4.5 | 0.504 | 7.6±2.7 | 7.9±2.4 | 0.386 |
| Lungs Dmean (Gy) | 7.24±0.61 | 7.32±0.58 | 0.014 | 8.41±0.63 | 8.50±0.61 | <0.001 |
Dosimetric results (mean ± standard deviation) of postmastectomy VMAT plans with 2 round and 3 round optimizations.
| 2 round (left-side) | 3 round (left-side) | p (left-side) | 2 round (right-side) | 3 round (right-side) | p (right-side) | |
|---|---|---|---|---|---|---|
| PTV CI | 0.850±0.011 | 0.854±0.012 | 0.002 | 0.846±0.012 | 0.851±0.011 | 0.027 |
| PTV HI | 0.148±0.015 | 0.143±0.014 | 0.003 | 0.150±0.019 | 0.142±0.015 | 0.002 |
| Heart Dmean (Gy) | 7.41±1.06 | 7.16±0.93 | 0.003 | 3.47±0.81 | 3.41±0.74 | 0.055 |
| Spinal cord D0.03cc (Gy) | 14.76±4.25 | 14.14±4.21 | <0.001 | 15.46±3.69 | 14.89±4.03 | 0.025 |
| Ipsilateral lung Dmean (Gy) | 13.17±0.72 | 12.95±0.72 | 0.001 | 13.65±0.72 | 13.53±0.63 | 0.010 |
| Ipsilateral lung V5Gy (%) | 48.7±4.2 | 47.4±3.6 | 0.009 | 49.3±3.7 | 48.4±3.3 | 0.006 |
| Ipsilateral lung V20Gy (%) | 23.0±1.3 | 22.5±1.4 | <0.001 | 24.2±0.9 | 23.9±0.8 | 0.001 |
| Contralateral lung Dmean (Gy) | 2.69±0.58 | 2.74±0.60 | 0.065 | 1.97±0.29 | 1.95±0.32 | 0.626 |
| Contralateral lung V5Gy (%) | 13.8±4.3 | 14.3±4.3 | 0.020 | 7.6±2.7 | 7.7±2.5 | 0.591 |
| Lungs Dmean (Gy) | 7.24±0.61 | 7.17±0.62 | <0.001 | 8.41±0.63 | 8.34±0.59 | 0.025 |
Iterations completed in each round of optimization of postmastectomy VMAT plans.
| Case no. | 1st round (left-side) | 2nd round (left-side) | 3rd round (left-side) | 1st round (right-side) | 2nd round (right-side) | 3rd round (right-side) |
|---|---|---|---|---|---|---|
| 1 | 100 | 100 | 10 | 100 | 100 | 100 |
| 2 | 100 | 93 | 31 | 100 | 100 | 38 |
| 3 | 100 | 100 | 93 | 100 | 100 | 93 |
| 4 | 100 | 100 | 65 | 100 | 100 | 93 |
| 5 | 100 | 100 | 100 | 100 | 100 | 12 |
| 6 | 100 | 100 | 93 | 100 | 100 | 12 |
| 7 | 100 | 100 | 26 | 100 | 100 | 100 |
| 8 | 100 | 100 | 100 | 100 | 100 | 12 |
| 9 | 100 | 100 | 100 | 100 | 100 | 93 |
| 10 | 100 | 100 | 100 | 100 | 100 | 93 |
Dosimetric results (mean ± standard deviation) of postmastectomy VMAT autoplans and clinical plans.
| Autoplan (left-side) | Clinical plan (left-side) | P (left-side) | Autoplan (right-side) | Clinical plan (right-side) | P (right-side) | |
|---|---|---|---|---|---|---|
| PTV CI | 0.854±0.012 | 0.812±0.056 | 0.042 | 0.851±0.011 | 0.842±0.009 | 0.002 |
| PTV HI | 0.143±0.014 | 0.204±0.103 | 0.083 | 0.142±0.015 | 0.169±0.027 | 0.004 |
| Heart Dmean (Gy) | 7.16±0.93 | 9.75±1.17 | <0.001 | 3.41±0.74 | 7.88±1.70 | <0.001 |
| Spinal cord D0.03cc (Gy) | 14.14±4.21 | 22.89±9.61 | 0.012 | 14.89±4.03 | 21.04±5.65 | 0.019 |
| Ipsilateral lung Dmean (Gy) | 12.95±0.72 | 14.02±0.92 | 0.012 | 13.53±0.63 | 14.17±0.46 | 0.003 |
| Ipsilateral lung V5Gy (%) | 47.4±3.6 | 58.2±5.9 | <0.001 | 48.4±3.3 | 57.9±4.2 | <0.001 |
| Ipsilateral lung V20Gy (%) | 22.5±1.4 | 23.8±2.4 | 0.197 | 23.9±0.8 | 24.2±1.2 | 0.644 |
| Contralateral lung Dmean (Gy) | 2.74±0.60 | 4.32±1.73 | 0.012 | 1.95±0.32 | 4.03±0.63 | <0.001 |
| Contralateral lung V5Gy (%) | 14.3±4.3 | 23.3±11.8 | 0.032 | 7.7±2.5 | 20.2±7.4 | <0.001 |
| Lungs Dmean (Gy) | 7.17±0.62 | 8.53±0.91 | <0.001 | 8.34±0.59 | 9.62±0.58 | <0.001 |
Figure 1Dose distribution and DVH for autoplan (left) and clinical plan (right) of 1 left-sided PMRT case. The blue colorwash area is PTV. The medium solid lines are isodose lines.
Figure 2Dose distribution and DVH for autoplan (left) and clinical plan (right) of 1 right-sided PMRT case. The blue colorwash area is PTV. The medium solid lines are isodose lines.